Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the results and potential impact from the phase 3 CEPHEUS trial.

Bertrand Y. Tuan, MD, hematologist/oncologist at Pacific Hematology Oncology Associates and California Pacific Medical Center ...

Targeted Oncology co-hosts Kristie L. Kahl and Andrew Svonavec highlight abstracts for community oncologists to look out for ...

Joe DePinto, MBA, discusses the complexity of the cell and gene therapy ecosystem and the need for collaboration with ...

TERN-701 showed promising early results, with significant molecular responses and a strong safety profile in heavily ...